AstraZeneca says its vaccine is 76 percent effective in an updated company analysis released after earlier challenges of its data

The new analysis was done after an independent data committee raised concerns with U.S. officials that the company had selectively used older data that cast its vaccine in a more favorable light.

View original article
Contributor: Carolyn Y. Johnson